The Cannabidiol Consumer Health market is estimated to be valued at US$ 19.0 Bn in 2023 and is expected to exhibit a CAGR of 23% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Cannabidiol or CBD is one of the primary cannabinoids extracted from hemp or marijuana plants. Products containing CBD are gaining popularity for their usefulness in wellness applications. CBD products are available in various forms such as oils, capsules, topical creams and others to provide relief from conditions like anxiety, insomnia, pain and inflammation. The growth in adoption of CBD-infused wellness products is expected to drive the cannabidiol consumer health market during the forecast period.

Market Dynamics:
The rising adoption of CBD products for wellness purposes acts as a major driver for the cannabidiol consumer health market growth. According to surveys, over 50% of CBD users reported using CBD to promote general well-being. CBD is known to have relaxing and soothing effects and is widely adopted to help manage stress and anxiety. Other conditions where CBD products find application include pain management, insomnia relief and inflammation reduction. The ability of CBD to provide therapeutic relief without psychoactive effects further fuels its demand. Additionally, the growing public awareness regarding benefits of CBD and legalization of hemp-derived CBD products in various regions also contributes to the market expansion. However, lack of standardized regulations for CBD products and risk of contamination restrict the market growth to some extent.

SWOT Analysis

Strength: The Cannabidiol Consumer Health Market has several therapeutic applications which gives it an advantage. CBD products are known to provide relief from anxiety, insomnia and chronic pain. CBD is also seen as a natural and organic alternative to prescription drugs. The market is experiencing rapid growth due to increasing legalization of cannabis-based products around the world.

Weakness: There is still confusion regarding the legality of CBD products in some countries which restricts the market growth. Lack of clinical research data and standardization around dosages of CBD also limits its acceptance among consumers.

Opportunity: Higher preference for natural and herbal products among consumers provides an opportunity for CBD products. Legalization of medical marijuana in more countries can help expand the market size and acceptance of CBD-based products.

Threats: Stringent regulations around the production, distribution and marketing of CBD products poses a threat. Substitutes present in the health and wellness market such as medicinal plants, yoga and meditation can divert consumer spending away from CBD products.

Key Takeaways:

The Global Cannabidiol (CBD) Consumer Health Market Size is expected to witness high growth, exhibiting CAGR of 23.% over the forecast period, due to increasing consumer preference for herbal and natural health remedies. Population aging is resulting in higher consumption of health and wellness products. Cannabis-derived CBD is seen as a safe alternative to pharmaceutical drugs for treatment of chronic conditions.

Regional analysis: North America dominates the global CBD consumer health market currently. The U.S. represents the largest regional market owing to legal acceptance and growing retail distribution of CBD products. Changing consumer attitudes and favorable government policies have also boosted the CBD industry in Canada. Europe is anticipated to present lucrative opportunities in the coming years led by countries like Germany, UK and France.

Key players operating in the Cannabidiol Consumer Health Market are CV Sciences, Inc., Medical Marijuana, Inc., AXIM-Biotechnologies, Inc., Charlotte's Web, Endoca, Isodiol International Inc., Elixinol, Folium Biosciences, NuLeaf Naturals, LLC, Cannoid, LLC, among others. The market is observing increasing partnerships between hemp farmers, CBD extractors and consumer product brands. Companies are investing in clinical trials to demonstrate therapeutic potential of CBD for regulatory approval and greater commercialization of products.

Get More Insights On This Topic: https://cmiresearch.blogspot.com/2023/12/cbd-infused-food-and-beverage-is.html